Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|5|2|197-206

ISSN： 1389-4501

Source： Current Drug Targets, Vol.5, Iss.2, 2004-01, pp. : 197-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurokinin Receptors as Potential Targets in Breast Cancer Treatment

By  

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 15-19

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic targets for Parkinson's disease

By Stoessl Jon  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 425-436

Informa Healthcare

Access to resources Recommend Favorite

New Approaches in the Treatment of Overactive Bladder: Targeting Adrenergic Receptors and Neurokinin Receptors

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 43-47

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-11 ,pp. : 777-791

Bentham Science Publishers

Access to resources Recommend Favorite